- US12570740utility2026Treatment for Physiological Iron Overload with an Anti-matriptase-2 Antibody0 cites
- US12473371utility2025Anti-opg Antibodies0 cites
- US12473378utility2025Antigen-binding Molecules Comprising Unpaired Variable Domains0 cites
- US12435134utility2025Antagonists Anti-cd7 Antibodies0 cites
- US12404330utility2025Antibodies to ICOS0 cites
- US12384855utility2025PCSK9 Antagonists0 cites
- US12209128utility2025Anti-pd-l1 Antibodies0 cites
- US11976135utility2024Fixaxfx Bispecific Antibody with Common Light Chain0 cites
- US11965026utility2024Anti-pd-l1 and IL-2 Cytokines0 cites
- US11919969utility2024Bispecific Antibodies for Factor IX and Factor X0 cites
- US11920128utility2024Methods, Cells and Organisms0 cites
- US11858996utility2024Anti-icos Antibodies0 cites
- US11820810utility2023Antibodies, Variable Domains and Chains Tailored for Human Use0 cites
- US11779604utility2023Antibodies, Combinations Comprising Antibodies, Biomarkers, Uses and Methods0 cites
- US11773175utility2023Antibodies, Uses and Methods0 cites
- US11753479utility2023Nucleic Acids Encoding Anti-ox40l Antibodies0 cites
- US11707056utility2023Animals, Repertoires and Methods0 cites
- US11680101utility2023Anti-opg Antibodies0 cites
- US11648308utility2023Methods, Regimens, Combinations and Antagonists0 cites
Page 1 of 2Next →